CELC | CelcuityNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$69.72
+$2.65 (+3.95%)

Celcuity (CELC) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA has sat below the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $69.72 vs 50 $76.72 / 200 $100.25
Projection
No cross projected
Test
No active test
Last cross
Death cross 29 Jul 2026 ยท projected 20 bars out ยท tested 1 bar

Weekly as of 30 Oct 16:00 ET

Price
between the two $69.13 vs 50 $100.59 / 200 $38.42
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 1 Apr 2024 ยท projected 28 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $69.72 vs 50 $66.79 / 200 $85.30
Projection
No cross projected
Test
No active test
Last cross
Death cross 16 Jun 2026 ยท projected 27 bars out

Cross history

23
crosses on record since 2019
11 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
29 Jul 2026Death steepdaily20 bars out1 bar cross test
16 Jun 2026Death4-hour27 bars outNot tested
24 Jul 2025Golden moderatedaily30 bars outNot tested
4 Jun 2025Golden4-hour16 bars outโ€”
30 Sep 2024Deathdaily20 bars outNot tested

About CELC

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$80.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.